鶹ýɫƬ

Lipid News

Studying protein–lipid interactions

John Burke
By John Burke
Oct. 1, 2018

Almost every signaling event in cells has a component that includes the recruitment of signaling proteins to lipid membranes. The proper recruitment, assembly and activation of these enzymes is integral to how cells live, divide and move. In recent years, we have seen a sea change in our ability to study lipid signaling systems, primarily through major advancements in cryo-electron microscopy and X-ray crystallography. This allows for molecular analysis of how integral membrane proteins are regulated and provides insight into novel strategies to treat myriad human diseases including cancer and metabolic syndrome.

One remaining challenge in characterizing lipid signaling at the molecular level is the study of peripheral membrane proteins and how they interact with lipids. These proteins (enzymes) reside in a cytosolic location in the absence of signals and, upon activation by various stimuli, are recruited to specific membrane surfaces to carry out their function. Misregulation of how lipid signaling enzymes are recruited to membranes is implicated directly in cancer and immune deficiencies. Researchers have used a variety of techniques to study this problem, including nuclear magnetic resonance, molecular dynamic simulations and other biophysical approaches (surface plasmon resonance, protein-lipid Förster resonance energy transfer, single molecular total internal reflection fluorescence microscopy and so on). All these approaches have distinct advantages and disadvantages, but together they provide unique insight into how proteins interact with and are recruited to specific membrane surfaces.

Hydrogen–deuterium exchange is a useful technique to probe conformational changes that occur upon small molecule, protein, and membrane interactions. Colors in the figure represent regions that undergo conformational changes in the bound state. Experiments require a comparison to an apo unbound state, with all conformational changes representing the sum total of both direct and allosteric conformational changes that occur upon binding. Courtesy of John BurkeA new tool used to study how proteins interact with lipid membranes is hydrogen–deuterium exchange mass spectrometry, or HDX-MS. This approach is conceptually simple, as hydrogens, specifically amide hydrogens, within proteins exchange with solvent, and this exchange is dependent primarily on the stability of protein secondary structure. This occurs because amide hydrogens are protected from exchange with solvent by their participation in hydrogen bonds in alpha helices and beta sheets. When a protein is shifted into a different chemical environment, in this case bound to a membrane, any regions with differences in protein conformation will experience a change in amide exchange. The exchange of individual amides is localized through digesting the protein and measuring the mass of fragments using a mass spectrometer. This can be compared across different conditions (apo, membrane bound, bound to specific lipids, disease-linked mutants and so on), revealing unique conformational changes for each.

The technique measures exchange rates throughout the entire protein, and conformational changes due to either direct membrane interactions or allosteric conformational changes will be observed. This is particularly useful in the study of large, complicated multidomain signaling complexes with experiments on the phosphoinositide 3-kinases revealing how previously undescribed disease-causing mutations mediate altered lipid signaling through unexpected allosteric conformational changes.

Due to great advances in the last decade in the instrumentation and software for HDX-MS experiments, studies examining protein complexes larger than 500 kDa on membrane surfaces are now commonplace. This provides the larger lipid signaling community with novel opportunities to more carefully define how peripheral membrane signaling complexes are regulated.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
John Burke
John Burke

John Burke is an assistant professor in the department of biochemistry and microbiology at the University of Victoria and winner of the 2018 ASBMB Shaw Young Investigator Award.

Related articles

Elusive zebrafish enzyme in lipid secretion
Isabel Casas & Emily Ulrich
Cholesterol lures in coronavirus
Marissa Locke Rottinghaus
A surprising modification lowers the lipid binding affinity of a membrane trafficking protein
Jefferson Knight, Colin T. Shearn & Cisloynny Beauchamp–Pérez

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.